9th U.S. Circuit Court of Appeals
Feb. 15, 2024
9th Circuit hears appeals of drug's deceptive advertising verdict
The panel heard two different appeals from the same case, which ended in a district court with a plaintiffs’ win for New York consumers and $8.3 million in statutory damages, along with another $4.6 million in prejudgment interest.
A 9th U.S. Circuit Court of Appeals panel considered cross-appeals Wednesday of a deceptive advertising verdict against the maker of a joint pain product that plaintiffs argued was “valueless” for its advertised purpose.
The panel heard two different appeals from the same case, which ended in a district court with a plaintiffs’ win for New York consumers and $8.3 million in statutory damages, along with another $4.6 million in prejudgment i...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In